CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection1

Primary viral infections, including primary HIV infection, trigger intense activation of the immune system, with marked expansion of CD38+CD8+ T cells. Whether this expansion involves only viral-specific cells or includes a degree of bystander activation remains a matter of debate. We therefore examined the activation status of EBV-, CMV-, and influenza virus (FLU)-specific CD8+ T cells during primary HIV infection, in comparison to HIV-specific CD8+ T cells. The activation markers CD38 and HLA-DR were strongly expressed on HIV-specific CD8+ T cells. Surprisingly, CD38 expression was also up-regulated on CD8+ T cells specific for other viruses, albeit to a lesser extent. Activation marker expression returned to normal or near-normal values after 1 year of highly active antiretroviral therapy. HIV viral load correlated with CD38 expression on HIV-specific CD8+ T cells but also on EBV-, CMV-, and FLU-specific CD8+ T cells. In primary HIV infection, EBV-specific CD8+ T cells also showed increased Ki67 expression and decreased Bcl-2 expression, compared with values observed in HIV-seronegative control subjects. These results show that bystander activation occurs during primary HIV infection, even though HIV-specific CD8+ T cells express the highest level of activation. The role of this bystander activation in lymphocyte homeostasis and HIV pathogenesis remains to be determined.

[1]  R. Welsh,et al.  Plasticity of T Cell Memory Responses to Viruses , 2004, Immunity.

[2]  R. V. van Lier,et al.  IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. , 2003, Blood.

[3]  J. Baatz,et al.  Cross-reactivity between HLA-A2-restricted FLU-M1:58–66 and HIV p17 GAG:77–85 epitopes in HIV-infected and uninfected individuals , 2003, Journal of Translational Medicine.

[4]  J. Corbeil,et al.  Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2. , 2003, The Journal of infectious diseases.

[5]  M. Gougeon,et al.  Cell death and immunity: Apoptosis as an HIV strategy to escape immune attack , 2003, Nature Reviews Immunology.

[6]  Matthew Jones,et al.  Interleukin 12-augmented T cell proliferation of peripheral blood mononuclear cells from HIV-seropositive individuals is associated with interleukin 12 receptor beta 2 upregulation. , 2003, AIDS research and human retroviruses.

[7]  R. Morisset,et al.  Studies on the Production of IL-15 in HIV-Infected/AIDS Patients , 2003, Journal of Clinical Immunology.

[8]  R. Koup,et al.  Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. , 2003, Immunity.

[9]  Marc Dalod,et al.  Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection. , 2003, The Journal of infectious diseases.

[10]  J. Altman,et al.  IL-15 enhances survival and function of HIV-specific CD8+ T cells. , 2003, Blood.

[11]  Stefan Kostense,et al.  Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue. , 2002, Trends in immunology.

[12]  S. Kostense,et al.  Lack of Epstein-Barr virus- and HIV-specific CD27− CD8+ T cells is associated with progression to viral disease in HIV-infection , 2002, AIDS.

[13]  R. Welsh,et al.  Dynamics of Memory T Cell Proliferation Under Conditions of Heterologous Immunity and Bystander Stimulation1 , 2002, The Journal of Immunology.

[14]  D. Richman,et al.  Dynamics of T Cell Responses in HIV Infection , 2002, The Journal of Immunology.

[15]  D. Richman,et al.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.

[16]  G. d’Ettorre,et al.  Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients , 2002, AIDS.

[17]  R. Koup,et al.  Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.

[18]  J. Bennink,et al.  Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells , 2001, Journal of Virology.

[19]  L Meyer,et al.  Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. , 2001, Blood.

[20]  W. Rozenbaum,et al.  Quantification of Epstein‐Barr virus load in peripheral blood of human immunodeficiency virus‐infected patients using real‐time PCR , 2001, Journal of medical virology.

[21]  B. Gazzard,et al.  Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. , 2001, Blood.

[22]  P. Burkett,et al.  T Cell–Independent Interleukin 15rα Signals Are Required for Bystander Proliferation , 2001, The Journal of experimental medicine.

[23]  F. Gheyas,et al.  Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. , 2001, Blood.

[24]  Raymond M. Welsh,et al.  Attrition of Bystander CD8 T Cells during Virus-Induced T-Cell and Interferon Responses , 2001, Journal of Virology.

[25]  J. Sprent,et al.  An IFN-γ-Dependent Pathway Controls Stimulation of Memory Phenotype CD8+ T Cell Turnover In Vivo by IL-12, IL-18, and IFN-γ1 , 2001, The Journal of Immunology.

[26]  P. Doherty,et al.  Virus-Specific and Bystander CD8+T-Cell Proliferation in the Acute and Persistent Phases of a Gammaherpesvirus Infection , 2001, Journal of Virology.

[27]  G. Stewart,et al.  In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12). , 2001, AIDS research and human retroviruses.

[28]  E. Rosenberg,et al.  Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection , 2001, The Journal of experimental medicine.

[29]  H. Macdonald,et al.  Selective Bystander Proliferation of Memory CD4+ and CD8+ T Cells Upon NK T or T Cell Activation , 2000, The Journal of Immunology.

[30]  S. Rowland-Jones,et al.  Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection , 2000, AIDS.

[31]  D. Pardoll,et al.  Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. , 1999, Immunity.

[32]  C. Rouzioux,et al.  Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. , 1999, The Journal of clinical investigation.

[33]  H. Naora,et al.  Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression , 1999, Cell Death and Differentiation.

[34]  J. Guillet,et al.  Broad, Intense Anti-Human Immunodeficiency Virus (HIV) Ex Vivo CD8+ Responses in HIV Type 1-Infected Patients: Comparison with Anti-Epstein-Barr Virus Responses and Changes during Antiretroviral Therapy , 1999, Journal of Virology.

[35]  G. Trinchieri,et al.  The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. , 1999, Blood.

[36]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[37]  J V Giorgi,et al.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.

[38]  Kaufmann,et al.  Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV‐1 infection correlates with markers of disease severity and changes towards normalization under treatment , 1999, Clinical and experimental immunology.

[39]  S. Rowland-Jones,et al.  A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. , 1999, Journal of immunology.

[40]  A. Rothman,et al.  Analysis of Murine CD8+ T-Cell Clones Specific for the Dengue Virus NS3 Protein: Flavivirus Cross-Reactivity and Influence of Infecting Serotype , 1999, Journal of Virology.

[41]  S. Varga,et al.  Protective Heterologous Antiviral Immunity and Enhanced Immunopathogenesis Mediated by Memory T Cell Populations , 1998, The Journal of experimental medicine.

[42]  D. Mason,et al.  A very high level of crossreactivity is an essential feature of the T-cell receptor. , 1998, Immunology today.

[43]  J. Sprent,et al.  Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. , 1998, Immunity.

[44]  J. Altman,et al.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.

[45]  M. Bevan,et al.  Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. , 1998, Immunity.

[46]  I. Frank,et al.  IL-15 enhances immune functions during HIV infection. , 1997, Journal of immunology.

[47]  R. Welsh,et al.  Minimal Bystander Activation of CD8 T Cells during the Virus-induced Polyclonal T Cell Response , 1997, The Journal of experimental medicine.

[48]  R. Zinkernagel,et al.  Bystander Activation of Cytotoxic T Cells: Studies on the Mechanism and Evaluation of In Vivo Significance in a Transgenic Mouse Model , 1997, The Journal of experimental medicine.

[49]  M. Dierich,et al.  Role of IL‐15 in HIV‐1‐associated hypergammaglobulinaemia , 1997, Clinical and experimental immunology.

[50]  X. Jin,et al.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL , 1996, Journal of virology.

[51]  N. Letvin,et al.  IL-15 stimulates the expansion of AIDS virus-specific CTL. , 1996, Journal of immunology.

[52]  M. Lederman,et al.  Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression. , 1996, The Journal of clinical investigation.

[53]  J. Bell,et al.  Large clonal expansions of CD8+ T cells in acute infectious mononucleosis , 1996, Nature Medicine.

[54]  J. Sprent,et al.  Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo , 1996, Science.

[55]  Persephone Borrow,et al.  Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV , 1994, Nature.

[56]  D. Ho,et al.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.

[57]  G. Trinchieri,et al.  Impaired interleukin 12 production in human immunodeficiency virus- infected patients , 1994, The Journal of experimental medicine.

[58]  R. Zinkernagel,et al.  Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. , 1992, Journal of immunology.

[59]  A. Fauci,et al.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. , 1988, Science.

[60]  M. Sinet,et al.  Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. , 1996, AIDS research and human retroviruses.